Deep Tech Startups

BioDit develops biometric security solutions offered in wireless and wired configurations. The company positions its products as security technology for access control and identity verification.

2 investors

Bioherent develops photonic biosensing technology for ultra-sensitive diagnostic detection of allergic and immunological responses. The company serves healthcare providers and patients needing faster, more accessible allergy and immunology diagnostics through proprietary light-based engineering.

2 investors

BioHeuris develops biotech tools using gene editing to improve weed control efficiency and crop production for farmers. The company works with seed companies, growers, and researchers to deploy genome-edited crop traits across soybean, cotton, and sorghum.

2 investors

BiomeBank develops microbiome-based therapies aimed at restoring the gut microbial ecosystem, with a focus on conditions such as inflammatory bowel disease and Clostridioides difficile infection. The company operates a cGMP manufacturing facility in Adelaide and works with academic and hospital research partners on drug discovery and clinical development.

2 investors

Biomemory develops DNA-based data storage, operating an integrated platform spanning molecular biology, biochemistry, hardware, software, and industrial DNA production for long-term data archiving. Spun out of Sorbonne University and CNRS, it serves the data storage market across Europe and North America.

2 investors

Biotheryx is a clinical-stage biopharmaceutical company developing first-in-class targeted protein degraders, including molecular glues and bifunctional degraders, with an initial focus on cancer and inflammatory disease. Its drug discovery work is built on modulating Cereblon and its proprietary PRODEGY platform.

2 investors

biotx.ai maps how genes causally shape human biology by systematically testing every human gene across tissues using large-scale Mendelian randomization, colocalization, and causal AI. This generates high-confidence causal links between genes, diseases, and biomarkers for drug target discovery.

2 investors

BioVersys is a clinical-stage biotech company focused on developing antimicrobial therapies to address unmet medical needs in infectious diseases, including tuberculosis and hospital-acquired infections. The company targets infectious disease indications with next-generation antimicrobial treatments.

2 investors

BIRD INITIATIVE is a Japanese R&D and digital innovation firm that accelerates promising technologies from research into business applications through simulation, automation, and ecosystem support. The company serves corporate clients and researchers seeking to commercialize digital transformation technologies.

2 investors

BitGPT is building a decentralized, chain-agnostic network for deploying, fine-tuning, and monetizing AI agents, enabling agents to collaborate and transact across different platforms. It emphasizes data sovereignty and security using privacy-preserving tools such as zero-knowledge proofs, personalized SLMs, and blind training protocols.

2 investors

Bitrobius develops gene therapy technologies, specifically the Gentrafix platform, leveraging microbial molecular biology and genetic engineering. The company serves therapeutic applications in areas including neurodegeneration and drug discovery.

2 investors

BKwai is a software platform that combines InSAR satellite and sensor monitoring data with data science and machine learning to provide structural health insights, movement mapping, and predictive forecasting. It serves engineers and asset operators for construction and asset monitoring across the design, construction, and operational stages of an asset's lifecycle.

2 investors

Blackbird Laboratories is a nonprofit life sciences incubator that translates university research breakthroughs into venture-ready biotech companies focused on developing new medicines and enabling technologies.

2 investors

Blaze Energy Technologies develops a Flex-Fuel Reformer System that retrofits existing marine vessels and future-proofs newbuilds to run on alternative fuels in their existing engines. The plug-and-play solution targets shipping fleet operators seeking regulatory compliance and fuel flexibility without dry dock work.

2 investors

Blue Current develops high-performance, safety-focused battery technology using a silicon-first design approach for both mobility and stationary energy storage applications. The company operates manufacturing and testing facilities in the Bay Area and serves automotive, consumer electronics, and energy storage markets.

2 investors

Blue Labs develops Blue-JST, a dual reward mechanism designed to balance relationships and utility, focused on building emotional intelligence into AI systems.

2 investors

Blue World Technologies develops high-temperature PEM methanol fuel cells that serve as clean energy solutions for industrial applications worldwide. The company aims to support decarbonization efforts across various sectors through fuel cell technology.

2 investors

Bluewater Bio develops water treatment and environmental engineering solutions, serving clients across construction, industrial, and infrastructure projects globally.

2 investors

BlueWhale Bio develops manufacturing technologies for cell-based therapies, focusing on cell activation and expansion in early-stage processing to improve efficiency and reduce costs. The company serves medical institutions and therapeutics developers working with cell therapy products.

2 investors

Insilico Medicine applies artificial intelligence to biomarker development and drug discovery. The company builds AI-driven tools to connect biomarker research with the process of discovering new drugs.

2 investors

Bonito develops encoded library and live-cell selection technologies to discover delivery ligands, generating high signal-to-noise data on membrane-bound targets to train AI models for precision drug delivery. The company combines functional selections with AI to turn physical delivery experiments into programmable ligand discovery.

2 investors

An AI company associated with scientist Tomáš Mikolov, whose research contributions include algorithms for scaling neural network language models and neural text generation methods used in chatbots.

2 investors

Bragi provides a platform for designing and manufacturing custom audio products and reference devices, partnering with leading ODMs and chipmakers to deliver hardware solutions.

2 investors

Braid develops AI-powered design and simulation tools for advanced manufacturing and engineering across aerospace, automotive, and other industrial sectors. The company combines human creativity with machine learning and physics-based computation to optimize product design and engineering workflows.

2 investors